These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The effect of manganese exposure in Atp13a2-deficient mice. Fleming SM; Santiago NA; Mullin EJ; Pamphile S; Karkare S; Lemkuhl A; Ekhator OR; Linn SC; Holden JG; Aga DS; Roth JA; Liou B; Sun Y; Shull GE; Schultheis PJ Neurotoxicology; 2018 Jan; 64():256-266. PubMed ID: 28595912 [TBL] [Abstract][Full Text] [Related]
27. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519 [TBL] [Abstract][Full Text] [Related]
28. ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein. Dhanushkodi NR; Abul Khair SB; Ardah MT; Haque ME Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675288 [TBL] [Abstract][Full Text] [Related]
29. The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity. Rinaldi DE; Corradi GR; Cuesta LM; Adamo HP; de Tezanos Pinto F Biochim Biophys Acta; 2015 Aug; 1848(8):1646-55. PubMed ID: 25912790 [TBL] [Abstract][Full Text] [Related]
30. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062 [TBL] [Abstract][Full Text] [Related]
31. Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation. Tsunemi T; Ishiguro Y; Yoroisaka A; Valdez C; Miyamoto K; Ishikawa K; Saiki S; Akamatsu W; Hattori N; Krainc D J Neurosci; 2020 Nov; 40(45):8618-8628. PubMed ID: 33046546 [TBL] [Abstract][Full Text] [Related]
32. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496 [TBL] [Abstract][Full Text] [Related]
33. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related]
34. α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. Kett LR; Stiller B; Bernath MM; Tasset I; Blesa J; Jackson-Lewis V; Chan RB; Zhou B; Di Paolo G; Przedborski S; Cuervo AM; Dauer WT J Neurosci; 2015 Apr; 35(14):5724-42. PubMed ID: 25855184 [TBL] [Abstract][Full Text] [Related]
35. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review. Yang X; Xu Y Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640 [TBL] [Abstract][Full Text] [Related]